CoChat
Sign Up
Cited by 3Gestational Diabetes Research and ManagementDiabetes Management and ResearchPregnancy and Medication Impact

Hyperglycemia in pregnancy — prevalence and perinatal outcomes. A retrospective multicenter cohort study in Poland

Open access
Bomba-Opoń, Dorota Agata, Godek, Bartosz, Czekaj, Lukasz, Huras, Hubert, Jakubiec-Wisniewska, Karolina, Janowiec, Krzysztof, Leszczynska-Gorzelak, Bozena, Slodzinska, Magdalena +12 more·2022·Ginekologia Polska
DOI 10.5603/gp.a2021.0257
Open this paper in CoChat — free account

Abstract

OBJECTIVES: Hyperglycemia in pregnancy (HIP) is one of the most common complications of pregnancy. Recently adopted new criteria for the diagnosis of HIP as well as the greater prevalence of risk factors could have a significant impact on HIP prevalence. The objective of the study was to assess the rates of HIP and the associated complications. MATERIAL AND METHODS: This was a retrospective analysis of clinical records from pregnant women who delivered in eight tertiary hospitals in Poland in 2016. RESULTS: The number of pregnant women with hyperglycemia totaled 1280 (7.25%), including gestational diabetes mellitus (GDM) in 1169 (6.62%) women and pregestational diabetes mellitus (PGDM) in 111 (0.63%). In addition to dietary modifications, 477 (41% of the GDM group) women received medical treatment (GDMG2). In women with PGDM multiple daily insulin injections (MDI) were used in 53 (47.7%) cases, continuous subcutaneous insulin infusions (CSII) in 57 (51.3%) cases and one woman was treated with metformin. The rate of cesarean sections was 69.4% and 62.9% for PGDM and GDM, respectively. Large-for-gestational-age (LGA) infants accounted for 38% and 21% of births in the PGDM and GDM groups, respectively. Of note are high rates of hyperbilirubinemia in infants born to mothers treated with insulin (13.5% for PGDM and 14.4% for GDMG2) vs infants born to mothers with diet (GDMG1) (3.4%). CONCLUSIONS: In Poland, the prevalence of HIP has nearly doubled in the past twenty years. Even with appropriate management, HIP is a significant risk factor for a cesarean section delivery, bearing an LGA infant and adverse neonatal outcomes.

Integrity signals

Registry

Crossref · 10.5603/gp.a2021.0257

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Poland, the gestational diabetes mellitus prevalence was 6.62% and it increased two-fold over the last 20 years.

    “Bomba-Opoń et al. in a retrospective multicenter cohort study presented the most actual data regarding the GDM prevalence in Poland—at 6.62% and it increased two-fold over the last 20 years [100].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [100]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Bomba-Opoń, D. A., Godek, B., Czekaj, L., Huras, H., Jakubiec-Wisniewska, K., Janowiec, K., Leszczynska-Gorzelak, B., Slodzinska, M., Zimmer, M., Bek, W., Rokita†, W., Zmelonek-Znamirowska, A., Kalinka, J., Biesiada, P., Stanczyk, P., Cnota, W., Malec, M., Laudanski, P., Zadykowicz, R., & Wielgos, M.
Affiliations
  • Medical University of Warsaw (PL)
  • Jagiellonian University (PL)
  • Medical University of Lublin (PL)
  • University of Wrocław (PL)
  • Jan Kochanowski University (PL)
  • Medical University of Lodz (PL)
  • Medical University of Silesia (PL)
  • Medical University of Białystok (PL)
ORCID
Venue
Ginekologia Polska
Publisher
VM Media SP. zo.o VM Group SK
Published
2022-03-07
Volume
93
Issue
12
Pages
1006-1012
ISSN
  • 0017-0011 (ISSN-L)
  • 2543-6767
DOI
10.5603/gp.a2021.0257
OpenAlex
W4221000531
Cited by
3
References
24
Citations by year
2023: 1 · 2022: 2
FWCI
0.75
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Ginekologia Polska (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
hyperglycemia in pregnancy, gestational diabetes mellitus, pregestational diabetes, prevalence, perinatal outcomes, cesarean section, large for gestational age, neonatal hyperbilirubinemia, insulin therapy, metformin, dietary management, Poland
MeSH terms
Birth Weight, Cesarean Section, Female, Humans, Hyperglycemia, Infant, Newborn, Insulin, Male, Poland, Pregnancy, Pregnancy Outcome, Retrospective Studies, Cohort Studies, Prevalence, Diabetes, Gestational, Parturition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review